Aeterna Zentaris to Present at Rodman & Renshaw 14th Annual Global Investment Conference in New York

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, Sept. 5, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that its President and\n CEO, Juergen Engel, PhD, will be presenting a corporate overview at the\n Rodman & Renshaw 14th Annual Global Investment Conference on Tuesday, September 11, 2012, at\n 1:35 pm (Eastern), in the Starlight North Room of The Waldorf=Astoria\n Hotel in New York.\n\n\nA live webcast of this presentation will be available on Aeterna\n Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is an oncology and endocrinology drug development\n company currently investigating treatments for various unmet medical\n needs. The Company's pipeline encompasses compounds at all stages of\n development, from drug discovery through to marketed products. For more\n information please visit www.aezsinc.com.\n\nSOURCE: AETERNA ZENTARIS INC.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":1559,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.